Evaluation of the efficacy of Maa-al-shaeer (product based on barley seeds) on radiotherapy induced dysuria
Phase 3
Recruiting
- Conditions
- Prostate Cancer, Radiotherapy-induced dysuria, Urogenital radiotherapy complications.C61Malignant
- Registration Number
- IRCT20190608043840N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 70
Inclusion Criteria
Over 18 years old
Prostate cancer
Candidate for radiation therapy (at the Radiotherapy Center of Shohada-e-Tajrish Hospital)
Consciousness
Exclusion Criteria
Unconsciousness or unable to report dysuria
Urinary catheter
Urinary tract infection
Diabetes Mellitus
Dysuria
A history of drug sensitivity
Metastasis
Chemotherapy at the same time
Hematuria
Severe Cardiovascular, Pulmonary, Hepatic and Kidney diseases that need some medical treatments
Not participating in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dysuria. Timepoint: Before intervention and 2, 4, 6, 8 weeks after intervention. Method of measurement: IPSS (International prostate symptom score) questionnaire.
- Secondary Outcome Measures
Name Time Method Quality of Life. Timepoint: Quality of life score before the intervention (week 0) 4 and 8 weeks after the intervention. Method of measurement: EORTC QLQ-PR25 Questionnaire (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Prostate Cancer).;The number of phenazopyridine tablets which was used. Timepoint: 2, 4, 6 and 8 weeks after the intervention. Method of measurement: Asking the participants.;Treatment satisfaction. Timepoint: 8 weeks after the intervention. Method of measurement: It is measured by asking 1 Likert scale question (very high, high, medium, low and very low).